Table 1.
Cell lines | Percentage focal adhesions per cell ± SEM (n = 50) | P-valuea | P-valueb |
---|---|---|---|
Jeg3 control | 100 ± 2.22 | ||
Jeg3 treated with S100P siRNA4 | 177.08 ± 4.54 | P < 0.0001 | |
Jeg3 treated with S100P siRNA6 | 190.38 ± 3.67 | P < 0.0001 | 0.4916 |
Bewo control | 100 ± 1.85 | ||
Bewo treated with S100P siRNA4 | 166.16 ± 3.04 | P < 0.0001 | |
Bewo treated with S100P siRNA6 | 171.57 ± 3.99 | P < 0.0001 | 0.9033 |
Jeg-3 and Bewo control cells, as well as cells treated with different S100P targeted siRNA for 72 hours were fixed and stained for paxillin and actin after seeding on fibronectin-coated coverslips. Data shown are means ± SEM corresponding to the average number of focal adhesion-containing paxillin observed per cell, presented as percentage of control. Untreated and mock treated controls (data not shown) were found to be not statistically significant (P > 0.05).
aP-value obtained from one-way ANOVA where total number of focal adhesions present in Jeg-3 or Bewo control cells were compared to previously S100P siRNA-treated counterparts.
bP-value obtained from one-way ANOVA where total number of focal adhesions present in Jeg-3 or Bewo cells treated with siRNA4 were compared to siRNA6-treated counterparts.